Sign Up to like & get
recommendations!
1
Published in 2021 at "Drug discovery today"
DOI: 10.1016/j.drudis.2021.06.015
Abstract: Delivering transformative therapies to patients while maintaining growth in the pharmaceutical industry requires an efficient use of research and development (R&D) resources and technologies to develop high-impact new molecular entities (NMEs). However, increasing global R&D…
read more here.
Keywords:
using new;
new risk;
risk;
risk map ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.03.574
Abstract: N ew-onset heart failure (HF) in children and adolescents, in the absence of congenital cardiac disease, is rare, estimated at 2.6 million young people, with and without structural cardiac disease, born between 1987 and 2012.…
read more here.
Keywords:
new risk;
heart;
factor early;
heart failure ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of cancer policy"
DOI: 10.1016/j.jcpo.2017.03.007
Abstract: Abstract Advances in understanding the biology of rare cancers and in genomic technologies are reshaping drug development and are fostering patients' hopes because an increasing number of drugs are expected to be made available. However,…
read more here.
Keywords:
risk sharing;
new risk;
rare cancers;
sharing paradigm ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Kybernetes"
DOI: 10.1108/k-03-2020-0184
Abstract: Purpose The healthcare system is regarded as one of the most critical service industries. The surgical unit is the heart of hospitals in that any failures directly affect the safety of patients, so they should…
read more here.
Keywords:
methodology;
new risk;
risk evaluation;
study ... See more keywords